dr ali mcbride discusses the role of biosimilars in oncology
Published 5 years ago • 240 plays • Length 5:59Download video MP4
Download video MP3
Similar videos
-
1:17
dr. mcbride on the emergence of biosimilars in oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
1:35
dr. mcbride on the potential of biosimilars in oncology
-
3:42
dr ali mcbride details the significance of his presidential theme in accc's 46th annual meeting
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
19:00
dr mia petljak, broad institute of mit and harvard, apobec-associated mutagenesis
-
44:08
15-years of biosimilars in europe: what lessons can we share? - panel 1
-
9:39
mpe masterclass 2022 | diagnosis and management of al amyloidosis
-
1:48
dr. markman on the concept of biosimilars in oncology
-
1:11
dr. mcbride on the regulatory pathway for biosimilars in oncology
-
11:39
part 2: ali mcbride discusses initiatives to improve physician education on biosimilars
-
1:27
dr. mcbride on biosimilar rituximab
-
2:00
ali mcbride, pharmd, ms, bcps: the impact of biosimilar pegfilgrastim
-
0:50
dr. ali on whether biosimilars can replace biologics in oncology
-
1:09
dr. ali on adjuvant studies with biosimilars in oncology
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
16:47
what is needed and what is the role of biosimilars?
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
2:04
dr. ali on incorporating biosimilars into cancer treatment
-
0:47
dr. o'regan discusses biosimilar education in oncology